

In the Top 50% of 2013 Similar Sized Companies on Comparably
1st place versus 4 competitors rated on Comparably
Carolyn Starrett oversees Flatiron Health’s community oncology and research businesses and all corporate functions.
She previously led Flatiron’s community oncology business, and succeeded Co-Founder Nat Turner as CEO on April 16, 2021.
Prior to joining Flatiron in 2016, Carolyn spent 10 years in senior strategy, product, and operations roles at data and technology companies, and five years consulting with healthcare and technology companies at Boston Consulting Group.
Carolyn holds a BA in economics and literature from Brown University and an MBA from the Kellogg School of Management.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Flatiron Health.
Based on 56 ratings, Carolyn Starrett ranks right above Foundation Medicine's CEO, Dan Malarek.
Flatiron Health's CEO is highly regarded by the HR department, employees with 6 to 10 Years experience, and the Operations department. However, employees with Over 10 Years experience, employees with 3 to 6 Years experience, and Male employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.
Flatiron Health ranks in the Top 50% of other companies on Comparably with 201-500 Employees for CEO Rating Score.
